Treace Medical Concepts announced the first successful procedures using its SpeedPlate MicroQuad implants.

The MicroQuad implant expands on the SpeedPlate’s broad utility, which the company said is designed for fast titanium compression fixation. The MicroQuad implant features multiple fixation points on each side of the joint to deliver dynamic compression, with rotational stability through a once-inch incision.

“The MicroQuad implant builds on the success of our proprietary SpeedPlate technology to provide a highly differentiated solution for fast, stable fixation designed to meet the growing surgeon and patient demand for minimally invasive Lapiplasty and Adductoplasty approaches,” said John T. Treace, CEO, founder, and board member of Treace. “We look forward to further expanding surgeon access to the MicroQuad implant as we move into full market release within the first half of 2025.”

William T. DeCarbo, DPM, of Greater Pittsburgh Foot & Ankle Center and a member of Treace’s Surgeon Advisory Board, who performed initial cases with the SpeedPlate MicroQuad implant, commented, “The MicroQuad implant takes the SpeedPlate system to a new level with an anatomic contour and additional rotational stability that gives me the clinical confidence I can deliver robust fixation through a small incision that patients desire.”

Earlier this month, Trace announced the successful completion of the first cases combining IntelliGuide PSI (patient-specific instrumentation) technology with the Adductoplasty system for a CT-based, patient-specific correction personalized to the patient’s unique midfoot deformity.